Trial intelligence / Profile preview

Acarbose on Endothelial Function in Newly Diagnosed Type 2 Diabetes

NCT00551954Phase 3Completed

Sponsor
Technische Universität Dresden
Start
Jul 2006
Primary completion
Jul 2007
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Acarbose with Placebo (2 arms). Primary endpoint: Forearm blood flow assessed by forearm occlusion plethysmography after a mixed meal at 20 weeks. Started Jul 2006; status: completed.

02

Drugs

acarbose
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00551954.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00551954.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call